{
  "id": "resp_07342e5a8426678200693c89d117f88195bad15e1ad5e20510",
  "object": "response",
  "created_at": 1765575121,
  "status": "completed",
  "background": false,
  "billing": {
    "payer": "developer"
  },
  "error": null,
  "incomplete_details": null,
  "instructions": null,
  "max_output_tokens": null,
  "max_tool_calls": null,
  "model": "gpt-5.2-2025-12-11",
  "output": [
    {
      "id": "rs_07342e5a8426678200693c89d1695c8195ab89349282ebaa73",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_07342e5a8426678200693c89d4eb788195bfe2ff5dcc4cc3bb",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "search",
        "query": "BRCA drug code BRCA"
      }
    },
    {
      "id": "rs_07342e5a8426678200693c89d6c314819598e690c940160bf0",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_07342e5a8426678200693c89e5b5bc819593330ad1fe0fea5c",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "search",
        "query": "BRCA acronym breast cancer susceptibility gene BRCA1 BRCA2 NCBI Gene"
      }
    },
    {
      "id": "rs_07342e5a8426678200693c89e867e881959ec9cc8c62ca4698",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_07342e5a8426678200693c8a0ae2c081959cc1f68ca6f39cd3",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "search",
        "query": "\"BRCA\" \"investigational\" drug"
      }
    },
    {
      "id": "rs_07342e5a8426678200693c8a0d6a5881959d8d5c26acca2b95",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "msg_07342e5a8426678200693c8a1bf38481958b4df26eb7814a48",
      "type": "message",
      "status": "completed",
      "content": [
        {
          "type": "output_text",
          "annotations": [],
          "logprobs": [],
          "text": "{\n  \"validated\": false,\n  \"assets\": [],\n  \"rejected_reason\": \"Candidate identifier \\\"BRCA\\\" refers to BRCA1/BRCA2 genes (a hereditary cancer risk biomarker / DNA-repair tumor suppressor genes), not a specific drug asset name/code; no drug named or coded \\\"BRCA\\\" with sponsor/target/modality/stage details could be identified. Evidence: https://medlineplus.gov/genetics/gene/brca1/ ; https://www.ncbi.nlm.nih.gov/books/n/gene/brca1/\"\n}"
        }
      ],
      "role": "assistant"
    }
  ],
  "parallel_tool_calls": true,
  "previous_response_id": null,
  "prompt_cache_key": null,
  "prompt_cache_retention": null,
  "reasoning": {
    "effort": "xhigh",
    "summary": null
  },
  "safety_identifier": null,
  "service_tier": "default",
  "store": true,
  "temperature": 1.0,
  "text": {
    "format": {
      "type": "text"
    },
    "verbosity": "medium"
  },
  "tool_choice": "auto",
  "tools": [
    {
      "type": "web_search",
      "filters": null,
      "search_context_size": "medium",
      "user_location": {
        "type": "approximate",
        "city": null,
        "country": "US",
        "region": null,
        "timezone": null
      }
    }
  ],
  "top_logprobs": 0,
  "top_p": 0.98,
  "truncation": "disabled",
  "usage": {
    "input_tokens": 19115,
    "input_tokens_details": {
      "cached_tokens": 4736
    },
    "output_tokens": 3772,
    "output_tokens_details": {
      "reasoning_tokens": 3650
    },
    "total_tokens": 22887
  },
  "user": null,
  "metadata": {}
}